We are delighted that our generative AI platform EMLy™️ has been shortlisted as a finalist in the AI Innovation category for the Fierce Innovation Awards: Life Sciences Edition 2024.
This recognition highlights the groundbreaking work we’re doing at Etcembly to revolutionise TCR discovery and accelerate immunotherapy development.
Congratulations to all the finalists - explore the full list here.
Comentários